FDA Inspection 617325 — BioMarin Pharmaceutical, Inc.
The FDA completed an inspection of BioMarin Pharmaceutical, Inc. on September 25, 2009 in Novato, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 25, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Postmarket Surv. and Epidemiology
- Location
- Novato, CA (United States)